Fibrobiologics Inc stock is traded at $0.97, with a volume of 2,801. It is up +1.39% in the last 24 hours and down -14.16% over the past month. FibroBiologics Inc a clinical-stage biotechnology company focused on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with unmet medical needs, including wound healing, multiple sclerosis, or MS, degenerative disc disease, psoriasis, certain cancers, and potential human longevity applications including thymic involution reversal using a thymic organoid. Its product candidates are CYWC628, CYPS317, CYMS101 and CybroCell.
Previous Close:
$0.9567
Open:
$0.94
24h Volume:
2,801
Relative Volume:
0.05
Market Cap:
$6.87M
Revenue:
-
Net Income/Loss:
-$18.68M
P/E Ratio:
-
EPS:
-$7.39
Net Cash Flow:
-$15.70M
1W Performance:
+4.30%
1M Performance:
-14.16%
6M Performance:
-24.81%
1Y Performance:
-85.53%
1-Day Range:
$0.9111$0.97
1-Week Range:
$0.9$1.04
52-Week Range:
$0.6201$9.60
Fibrobiologics Inc Stock (FBLG) Company Profile
Name
Fibrobiologics IncSector
HealthcareIndustry
BiotechnologyPhone
281-671-5150Address
455 E. MEDICAL CENTER BLVD, HOUSTON, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS